Vycor Medical, Inc. VYCO
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.30K | 20.10K | -62.70K | 4.90K | 23.90K |
| Total Depreciation and Amortization | 14.40K | 15.70K | 16.10K | 15.90K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00 | 9.50K | 300.00 | 15.00K | 18.50K |
| Change in Net Operating Assets | 3.00K | 54.20K | 85.50K | -108.20K | -10.80K |
| Cash from Operations | -4.80K | 99.40K | 39.20K | -72.40K | 46.60K |
| Capital Expenditure | -- | -- | -1.60K | 0.00 | -3.60K |
| Sale of Property, Plant, and Equipment | 300.00 | 2.10K | 0.00 | 0.00 | 800.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 300.00 | 2.10K | -1.60K | 0.00 | -2.80K |
| Total Debt Issued | -- | -- | 0.00 | 59.00K | -- |
| Total Debt Repaid | -10.20K | -14.90K | -14.90K | -22.10K | -5.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.20K | -14.90K | -14.90K | 37.00K | -5.20K |
| Foreign Exchange rate Adjustments | 0.00 | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.70K | 86.70K | 22.80K | -35.50K | 38.70K |